학술논문

Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma
Document Type
Article
Source
In: European Journal of Cancer. (European Journal of Cancer, February 2020, 126:1-10)
Subject
Language
English
ISSN
18790852
09598049